Research

Associations between HLA and autoimmune neurological diseases with autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065322/

Psychiatric Manifestation of Anti-LGI1 Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348933/

Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448167/

Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624087/

New-Onset Refractory Status Epilepticus with Underlying Autoimmune Etiology: a Case Report February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223986/

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003900/

Hashimoto’s encephalopathy: Follow-up data from neuropsychology, lumbar puncture, and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745505/

S100A6 Promotes B Lymphocyte Penetration Through the Blood-Brain Barrier in Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901080/